New England Journal of Medicine

Vaccination

UK may take part in COVID-19 vaccine 'challenge studies'

The British government says it may take part in a study that tries to deliberately infect volunteers who have been given an experimental vaccine against the coronavirus in an effort to more quickly determine if the vaccine ...

Oncology & Cancer

Targeted drug for lung cancer approved for NHS use in England

In two decisions published today, the National Institute for Health and Care Excellence (NICE) has approved the drug osimertinib (Tagrisso) to treat some adults in England with advanced lung cancer whose cancer tests positive ...

Diseases, Conditions, Syndromes

Large antibody study offers hope for virus vaccine efforts

Antibodies that people make to fight the new coronavirus last for at least four months after diagnosis and do not fade quickly as some earlier reports suggested, scientists have found.

Medications

Adding belimumab improves renal outcome in lupus nephritis

(HealthDay)—The addition of belimumab versus placebo to standard therapy increases the likelihood of a primary efficacy renal response in patients with active lupus nephritis, according to a study published in the Sept. ...

page 3 from 4